{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:04:52Z","timestamp":1785168292001,"version":"3.55.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/md.0000000000002995","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T12:33:51Z","timestamp":1457613231000},"page":"e2995","source":"Crossref","is-referenced-by-count":24,"title":["Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection"],"prefix":"10.1097","volume":"95","author":[{"given":"Wan-Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Chung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chih","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung-Hung","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Fang-Tzu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Shinn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-46-20210226","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12072-009-9147-9","article-title":"Dual chronic hepatitis B virus and hepatitis C virus infection","volume":"3","author":"Liu","year":"2009","journal-title":"Hepatol Int"},{"key":"R2-46-20210226","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.gastro.2004.01.011","article-title":"Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection","volume":"126","author":"Liaw","year":"2004","journal-title":"Gastroenterology"},{"key":"R3-46-20210226","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1200\/JCO.2011.36.2335","article-title":"Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C","volume":"29","author":"Huang","year":"2011","journal-title":"J Clin Oncol"},{"key":"R4-46-20210226","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"R5-46-20210226","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/infdis\/163.2.400","article-title":"Hepatitis C virus infection in chronic hepatitis B virus carriers","volume":"163","author":"Fattovich","year":"1991","journal-title":"J Infect Dis"},{"key":"R6-46-20210226","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0168-8278(05)80389-7","article-title":"Coinfection of hepatitis C virus in patients with chronic hepatitis B infection","volume":"21","author":"Sato","year":"1994","journal-title":"J Hepatol"},{"key":"R7-46-20210226","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1128\/JCM.36.7.2084-2086.1998","article-title":"Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection","volume":"36","author":"Chu","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R8-46-20210226","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1053\/j.gastro.2011.04.046","article-title":"Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters","volume":"141","author":"Tseng","year":"2011","journal-title":"Gastroenterology"},{"key":"R9-46-20210226","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2012.02.007","article-title":"High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load","volume":"142","author":"Tseng","year":"2012","journal-title":"Gastroenterology"},{"key":"R10-46-20210226","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"R11-46-20210226","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jcu.1870210502","article-title":"Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study","volume":"21","author":"Lin","year":"1993","journal-title":"J Clin Ultrasound"},{"key":"R12-46-20210226","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"R13-46-20210226","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s005350300025","article-title":"Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis","volume":"38","author":"Hung","year":"2003","journal-title":"J Gastroenterol"},{"key":"R14-46-20210226","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"R15-46-20210226","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2004.06.031","article-title":"Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis","volume":"41","author":"Yeh","year":"2004","journal-title":"J Hepatol"},{"key":"R16-46-20210226","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/infdis\/jit209","article-title":"Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers","volume":"208","author":"Tseng","year":"2013","journal-title":"J Infect Dis"},{"key":"R17-46-20210226","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/infdis\/jis569","article-title":"Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation","volume":"206","author":"Tseng","year":"2012","journal-title":"J Infect Dis"},{"key":"R18-46-20210226","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/apt.13170","article-title":"Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection","volume":"41","author":"Tseng","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-46-20210226","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/hep.24615","article-title":"Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load","volume":"55","author":"Tseng","year":"2012","journal-title":"Hepatology"},{"key":"R20-46-20210226","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000105444","article-title":"Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan","volume":"50","author":"Hsu","year":"2007","journal-title":"Intervirology"},{"key":"R21-46-20210226","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1200\/JCO.2010.29.1500","article-title":"Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study","volume":"28","author":"Lee","year":"2010","journal-title":"J Clin Oncol"},{"key":"R22-46-20210226","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1128\/JCM.01856-09","article-title":"New automated hepatitis C virus (HCV) core antigen assay as an alternative to real-time PCR for HCV RNA quantification","volume":"48","author":"Park","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R23-46-20210226","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.24121","article-title":"Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)","volume":"53","author":"Jung","year":"2011","journal-title":"Hepatology"},{"key":"R24-46-20210226","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2013.09.029","article-title":"Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B","volume":"60","author":"Wong","year":"2014","journal-title":"J Hepatol"},{"key":"R25-46-20210226","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1002\/hep.22870","article-title":"Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography","volume":"49","author":"Masuzaki","year":"2009","journal-title":"Hepatology"},{"key":"R26-46-20210226","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27382","article-title":"Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis","volume":"61","author":"Xiao","year":"2015","journal-title":"Hepatology"},{"key":"R27-46-20210226","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R28-46-20210226","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/MCG.0000000000000250","article-title":"Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B","volume":"49","author":"Lin","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"R29-46-20210226","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-137-8-200210150-00015","article-title":"Rare outcomes, common treatments: analytic strategies using propensity scores","volume":"137","author":"Braitman","year":"2002","journal-title":"Ann Intern Med"},{"key":"R30-46-20210226","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1074\/jbc.M204241200","article-title":"Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein","volume":"278","author":"Chen","year":"2003","journal-title":"J Biol Chem"},{"key":"R31-46-20210226","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.22951","article-title":"Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference","volume":"50","author":"Bellecave","year":"2009","journal-title":"Hepatology"},{"key":"R32-46-20210226","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jhep.2009.09.002","article-title":"Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice","volume":"51","author":"Hiraga","year":"2009","journal-title":"J Hepatol"},{"key":"R33-46-20210226","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10620-012-2343-9","article-title":"Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without","volume":"58","author":"Chu","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R34-46-20210226","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ni.2573","article-title":"Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection","volume":"14","author":"Huang","year":"2013","journal-title":"Nature Immunol"},{"key":"R35-46-20210226","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/2053","article-title":"The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice","volume":"4","author":"Moriya","year":"1998","journal-title":"Nature Med"},{"key":"R36-46-20210226","first-page":"683","article-title":"PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice","volume":"118","author":"Tanaka","year":"2008","journal-title":"J Clin Invest"},{"key":"R37-46-20210226","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1053\/gast.2002.36026","article-title":"Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection","volume":"123","author":"Chen","year":"2002","journal-title":"Gastroenterology"},{"key":"R38-46-20210226","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/infdis\/jiu659","article-title":"Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: external validation of a scoring system","volume":"211","author":"Liu","year":"2015","journal-title":"J Infect Dis"},{"key":"R39-46-20210226","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/gutjnl-2012-304370","article-title":"Treatment of patients with dual hepatitis C and B by peginterferon alpha and ribavirin reduced risk of hepatocellular carcinoma and mortality","volume":"63","author":"Liu","year":"2014","journal-title":"Gut"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000002995","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:19:15Z","timestamp":1620958755000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201603080-00046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002995","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}